| KQL | Name: | N-(4-methylpyridin-3-yl)-2-[3-(trifluoromethyl)phenyl]acetamide | Formula: | C15 H13 F3 N2 O | SMILES: | O=C(Nc1cnccc1C)Cc1cccc(c1)C(F)(F)F | InChi: | InChI=1S/C15H13F3N2O/c1-10-5-6-19-9-13(10)20-14(21)8-11-3-2-4-12(7-11)15(16,17)18/h2-7,9H,8H2,1H3,(H,20,21) | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(4-methylpyridin-3-yl)-2-[3-(trifluoromethyl)phenyl]acetamide |
|
| Y1Y | Name: | 3-amino-2,3-dideoxy-5-O-(5-methylthiophene-2-carbonyl)-D-erythro-pentonic acid | Formula: | C11 H15 N O5 S | SMILES: | Cc1sc(cc1)C(=O)OCC(C(N)CC(O)=O)O | InChi: | InChI=1S/C11H15NO5S/c1-6-2-3-9(18-6)11(16)17-5-8(13)7(12)4-10(14)15/h2-3,7-8,13H,4-5,12H2,1H3,(H,14,15)/t7-,8+/m0/s1 | Definition date: | 2020-06-02 | Last modified: | 2023-11-03 | Release date: | 2021-06-02 | Identifier: | 3-amino-2,3-dideoxy-5-O-(5-methylthiophene-2-carbonyl)-D-erythro-pentonic acid |
|
| YJO | Name: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(2~{S},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,5-bis(oxidanyl)-4-[4-[oxidanyl(phenyl)-$l^{3}-sulfanyl]-1,2,3-triazol-1-yl]oxan-2-yl]sulfanyl-oxane-3,4,5-triol | Formula: | C20 H28 N3 O10 S2 | SMILES: | OC[CH]1O[CH](S[CH]2O[CH](CO)[CH](O)[CH]([CH]2O)n3cc(nn3)[S+](O)c4ccccc4)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C20H28N3O10S2/c24-7-10-14(26)13(23-6-12(21-22-23)35(31)9-4-2-1-3-5-9)16(28)19(32-10)34-20-18(30)17(29)15(27)11(8-25)33-20/h1-6,10-11,13-20,24-31H,7-8H2/q+1/t10-,11-,13+,14+,15-,16-,17+,18-,19+,20+,35-/m1/s1 | Definition date: | 2023-06-19 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | [1-[(2~{R},3~{R},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(2~{S},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]sulfanyl-3,5-bis(oxidanyl)oxan-4-yl]-1,2,3-triazol-4-yl]-oxidanyl-phenyl-sulfanium |
|
| VQK | Name: | N-(3-{2-[5-chloro-2-(3-chloro-5-cyanophenoxy)phenoxy]ethyl}phenyl)prop-2-enamide | Formula: | C24 H18 Cl2 N2 O3 | SMILES: | Clc1cc(OCCc2cccc(NC(=O)C=C)c2)c(Oc2cc(C#N)cc(Cl)c2)cc1 | InChi: | InChI=1S/C24H18Cl2N2O3/c1-2-24(29)28-20-5-3-4-16(11-20)8-9-30-23-14-18(25)6-7-22(23)31-21-12-17(15-27)10-19(26)13-21/h2-7,10-14H,1,8-9H2,(H,28,29) | Definition date: | 2023-09-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(3-{2-[5-chloro-2-(3-chloro-5-cyanophenoxy)phenoxy]ethyl}phenyl)prop-2-enamide |
|
| KQX | Name: | 2-(4-methylphenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C15 H16 N2 O | SMILES: | O=C(Nc1cnccc1C)Cc1ccc(C)cc1 | InChi: | InChI=1S/C15H16N2O/c1-11-3-5-13(6-4-11)9-15(18)17-14-10-16-8-7-12(14)2/h3-8,10H,9H2,1-2H3,(H,17,18) | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(4-methylphenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
| VQT | Name: | (4M)-4-(6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-7-yl)-7-fluoro-1,3-benzothiazol-2-amine | Formula: | C29 H29 Cl F3 N7 O S | SMILES: | FC1CC2(CCCN2C1)COc1nc2c(F)c(c3ccc(F)c4sc(N)nc34)c(Cl)cc2c(n1)N1CC2CCC(N2)C1 | InChi: | InChI=1S/C29H29ClF3N7OS/c30-19-8-18-23(22(33)21(19)17-4-5-20(32)25-24(17)36-27(34)42-25)37-28(38-26(18)39-11-15-2-3-16(12-39)35-15)41-13-29-6-1-7-40(29)10-14(31)9-29/h4-5,8,14-16,35H,1-3,6-7,9-13H2,(H2,34,36)/t14-,15-,16+,29+/m1/s1 | Definition date: | 2023-09-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4M)-4-(6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-7-yl)-7-fluoro-1,3-benzothiazol-2-amine |
|
| VR0 | Name: | N~5~-[N-(methylcarbamoyl)carbamimidoyl]-L-ornithine | Formula: | C8 H17 N5 O3 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])NC(=O)NC | InChi: | InChI=1S/C8H17N5O3/c1-11-8(16)13-7(10)12-4-2-3-5(9)6(14)15/h5H,2-4,9H2,1H3,(H,14,15)(H4,10,11,12,13,16)/t5-/m0/s1 | Definition date: | 2010-11-01 | Last modified: | 2023-11-03 | Identifier: | N~5~-[N-(methylcarbamoyl)carbamimidoyl]-L-ornithine |
|
| U3X | Name: | 4-[(cyclohexylmethyl)amino]-L-phenylalanine | Formula: | C16 H24 N2 O2 | SMILES: | O=C(O)C(N)Cc2ccc(NCC1CCCCC1)cc2 | InChi: | InChI=1S/C16H24N2O2/c17-15(16(19)20)10-12-6-8-14(9-7-12)18-11-13-4-2-1-3-5-13/h6-9,13,15,18H,1-5,10-11,17H2,(H,19,20)/t15-/m0/s1 | Definition date: | 2013-05-06 | Last modified: | 2023-11-03 | Release date: | 2013-06-19 | Identifier: | 4-[(cyclohexylmethyl)amino]-L-phenylalanine |
|
| VR5 | Name: | (4P)-2-amino-4-{4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}-6-(trifluoromethyl)quinazolin-7-yl}-7-fluoro-1-benzothiophene-3-carbonitrile | Formula: | C32 H29 F6 N7 O S | SMILES: | FC(F)(F)c1cc2c(nc(OCC34CCCN4CC(F)C3)nc2c(F)c1c1ccc(F)c2sc(N)c(C#N)c12)N1CC2CCC(N2)C1 | InChi: | InChI=1S/C32H29F6N7OS/c33-15-9-31(6-1-7-45(31)11-15)14-46-30-42-26-19(29(43-30)44-12-16-2-3-17(13-44)41-16)8-21(32(36,37)38)24(25(26)35)18-4-5-22(34)27-23(18)20(10-39)28(40)47-27/h4-5,8,15-17,41H,1-3,6-7,9,11-14,40H2/t15-,16-,17+,31+/m1/s1 | Definition date: | 2023-09-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4P)-2-amino-4-{4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}-6-(trifluoromethyl)quinazolin-7-yl}-7-fluoro-1-benzothiophene-3-carbonitrile |
|
| WPA | Name: | (betaR)-beta-methoxy-L-phenylalanine | Formula: | C10 H13 N O3 | SMILES: | O=C(O)C(N)C(OC)c1ccccc1 | InChi: | InChI=1S/C10H13NO3/c1-14-9(8(11)10(12)13)7-5-3-2-4-6-7/h2-6,8-9H,11H2,1H3,(H,12,13)/t8-,9+/m0/s1 | Definition date: | 2013-06-18 | Last modified: | 2023-11-03 | Release date: | 2013-09-18 | Identifier: | (betaR)-beta-methoxy-L-phenylalanine |
|
| VR9 | Name: | N-[2-(5-chloro-2-{[(4R)-2-cyanoindolizin-8-yl]oxy}phenoxy)ethyl]-N-methylpropanamide | Formula: | C21 H20 Cl N3 O3 | SMILES: | CCC(=O)N(C)CCOc1cc(Cl)ccc1Oc1cccn2cc(cc12)C#N | InChi: | InChI=1S/C21H20ClN3O3/c1-3-21(26)24(2)9-10-27-20-12-16(22)6-7-19(20)28-18-5-4-8-25-14-15(13-23)11-17(18)25/h4-8,11-12,14H,3,9-10H2,1-2H3 | Definition date: | 2023-09-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-[2-(5-chloro-2-{[(4R)-2-cyanoindolizin-8-yl]oxy}phenoxy)ethyl]-N-methylpropanamide |
|
| VRF | Name: | N-(2-{2-[(6-cyanonaphthalen-1-yl)oxy]phenoxy}ethyl)-N-methylprop-2-enamide | Formula: | C23 H20 N2 O3 | SMILES: | C=CC(=O)N(C)CCOc1ccccc1Oc1cccc2cc(C#N)ccc21 | InChi: | InChI=1S/C23H20N2O3/c1-3-23(26)25(2)13-14-27-21-8-4-5-9-22(21)28-20-10-6-7-18-15-17(16-24)11-12-19(18)20/h3-12,15H,1,13-14H2,2H3 | Definition date: | 2023-09-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(2-{2-[(6-cyanonaphthalen-1-yl)oxy]phenoxy}ethyl)-N-methylprop-2-enamide |
|
| 0UO | Name: | 4-methoxy-L-tryptophan | Formula: | C12 H14 N2 O3 | SMILES: | O=C(O)C(N)Cc2c1c(cccc1OC)nc2 | InChi: | InChI=1S/C12H14N2O3/c1-17-10-4-2-3-9-11(10)7(6-14-9)5-8(13)12(15)16/h2-4,6,8,14H,5,13H2,1H3,(H,15,16)/t8-/m0/s1 | Definition date: | 2012-06-20 | Last modified: | 2023-11-03 | Release date: | 2012-09-21 | Identifier: | 4-methoxy-L-tryptophan |
|
| UX8 | Name: | (2~{S},3~{R})-2-azanyl-3-(1~{H}-indol-3-yl)-3-oxidanyl-propanoic acid | Formula: | C11 H12 N2 O3 | SMILES: | N[CH]([CH](O)c1c[nH]c2ccccc12)C(O)=O | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)10(14)7-5-13-8-4-2-1-3-6(7)8/h1-5,9-10,13-14H,12H2,(H,15,16)/t9-,10+/m0/s1 | Definition date: | 2021-03-25 | Last modified: | 2023-11-03 | Release date: | 2021-04-21 | Identifier: | (2~{S},3~{R})-2-azanyl-3-(1~{H}-indol-3-yl)-3-oxidanyl-propanoic acid |
|
| KS0 | Name: | 1-{4-[(4-fluorophenyl)methyl]piperazin-1-yl}propan-1-one | Formula: | C14 H19 F N2 O | SMILES: | CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1 | InChi: | InChI=1S/C14H19FN2O/c1-2-14(18)17-9-7-16(8-10-17)11-12-3-5-13(15)6-4-12/h3-6H,2,7-11H2,1H3 | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-{4-[(4-fluorophenyl)methyl]piperazin-1-yl}propan-1-one |
|
| VRQ | Name: | N-(2-{5-chloro-2-[(6-cyanonaphthalen-1-yl)oxy]phenoxy}ethyl)-N-methylprop-2-enamide | Formula: | C23 H19 Cl N2 O3 | SMILES: | Clc1cc(OCCN(C)C(=O)C=C)c(Oc2cccc3cc(C#N)ccc23)cc1 | InChi: | InChI=1S/C23H19ClN2O3/c1-3-23(27)26(2)11-12-28-22-14-18(24)8-10-21(22)29-20-6-4-5-17-13-16(15-25)7-9-19(17)20/h3-10,13-14H,1,11-12H2,2H3 | Definition date: | 2023-09-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(2-{5-chloro-2-[(6-cyanonaphthalen-1-yl)oxy]phenoxy}ethyl)-N-methylprop-2-enamide |
|
| KSI | Name: | 1-[(3S)-4-[(3-chlorophenyl)methyl]-3-(2-methylpropyl)piperazin-1-yl]ethan-1-one | Formula: | C17 H25 Cl N2 O | SMILES: | CC(C)CC1CN(CCN1Cc1cc(Cl)ccc1)C(C)=O | InChi: | InChI=1S/C17H25ClN2O/c1-13(2)9-17-12-19(14(3)21)7-8-20(17)11-15-5-4-6-16(18)10-15/h4-6,10,13,17H,7-9,11-12H2,1-3H3/t17-/m0/s1 | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-[(3S)-4-[(3-chlorophenyl)methyl]-3-(2-methylpropyl)piperazin-1-yl]ethan-1-one |
|
| 74P | Name: | (E)-N~6~-(1-carboxy-3-oxobutylidene)-L-lysine | Formula: | C11 H18 N2 O5 | SMILES: | C(C/C(=NCCCCC(N)C(O)=O)C(=O)O)(C)=O | InChi: | InChI=1S/C11H18N2O5/c1-7(14)6-9(11(17)18)13-5-3-2-4-8(12)10(15)16/h8H,2-6,12H2,1H3,(H,15,16)(H,17,18)/b13-9+/t8-/m0/s1 | Definition date: | 2016-08-24 | Last modified: | 2023-11-03 | Release date: | 2016-10-05 | Identifier: | (E)-N~6~-(1-carboxy-3-oxobutylidene)-L-lysine |
|
| KSX | Name: | 2-(5-cyanopyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C14 H12 N4 O | SMILES: | O=C(Nc1cnccc1C)Cc1cc(C#N)cnc1 | InChi: | InChI=1S/C14H12N4O/c1-10-2-3-16-9-13(10)18-14(19)5-11-4-12(6-15)8-17-7-11/h2-4,7-9H,5H2,1H3,(H,18,19) | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(5-cyanopyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide |
|
| VDE | Name: | (2S)-2-azanyl-6-[4-[(2S)-2,3-bis(azanyl)-3-oxidanylidene-propyl]-1,2,3-triazol-1-yl]hexanoic acid | Formula: | C11 H20 N6 O3 | SMILES: | N[CH](CCCCn1cc(C[CH](N)C(N)=O)nn1)C(O)=O | InChi: | InChI=1S/C11H20N6O3/c12-8(11(19)20)3-1-2-4-17-6-7(15-16-17)5-9(13)10(14)18/h6,8-9H,1-5,12-13H2,(H2,14,18)(H,19,20)/t8-,9-/m0/s1 | Definition date: | 2021-05-06 | Last modified: | 2023-11-03 | Release date: | 2023-04-26 | Identifier: | (2~{S})-2-azanyl-6-[4-[(2~{S})-2,3-bis(azanyl)-3-oxidanylidene-propyl]-1,2,3-triazol-1-yl]hexanoic acid |
|
| KT9 | Name: | N-(3-methyl-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide | Formula: | C16 H16 N4 O3 | SMILES: | Cc1cc(cc(OC2CC(=O)N2)c1)NC(=O)Cc1cncnc1 | InChi: | InChI=1S/C16H16N4O3/c1-10-2-12(5-13(3-10)23-16-6-15(22)20-16)19-14(21)4-11-7-17-9-18-8-11/h2-3,5,7-9,16H,4,6H2,1H3,(H,19,21)(H,20,22)/t16-/m0/s1 | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(3-methyl-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide |
|
| KU6 | Name: | (4R)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | Formula: | C15 H15 Cl N4 O2 | SMILES: | Clc1ccc2OCCC(c2c1)C(=O)Nc1nncn1C1CC1 | InChi: | InChI=1S/C15H15ClN4O2/c16-9-1-4-13-12(7-9)11(5-6-22-13)14(21)18-15-19-17-8-20(15)10-2-3-10/h1,4,7-8,10-11H,2-3,5-6H2,(H,18,19,21)/t11-/m1/s1 | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| KUU | Name: | (2R)-2-(3-chlorophenyl)-3-methyl-N-(4-methylpyridin-3-yl)butanamide | Formula: | C17 H19 Cl N2 O | SMILES: | O=C(Nc1cnccc1C)C(c1cccc(Cl)c1)C(C)C | InChi: | InChI=1S/C17H19ClN2O/c1-11(2)16(13-5-4-6-14(18)9-13)17(21)20-15-10-19-8-7-12(15)3/h4-11,16H,1-3H3,(H,20,21)/t16-/m1/s1 | Definition date: | 2023-08-14 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2R)-2-(3-chlorophenyl)-3-methyl-N-(4-methylpyridin-3-yl)butanamide |
|
| JLP | Name: | (2S)-2-azanyl-6-[E-[5-(hydroxymethyl)-2-methyl-3-oxidanyl-pyridin-4-yl]methylideneamino]hexanoic acid | Formula: | C14 H21 N3 O4 | SMILES: | Cc1ncc(CO)c(C=NCCCC[CH](N)C(O)=O)c1O | InChi: | InChI=1S/C14H21N3O4/c1-9-13(19)11(10(8-18)6-17-9)7-16-5-3-2-4-12(15)14(20)21/h6-7,12,18-19H,2-5,8,15H2,1H3,(H,20,21)/b16-7+/t12-/m0/s1 | Definition date: | 2018-06-03 | Last modified: | 2023-11-03 | Release date: | 2019-05-29 | Identifier: | (2~{S})-2-azanyl-6-[(~{E})-[5-(hydroxymethyl)-2-methyl-3-oxidanyl-pyridin-4-yl]methylideneamino]hexanoic acid |
|
| KV6 | Name: | (3R)-3-aminoheptadecanoic acid | Formula: | C17 H35 N O2 | SMILES: | NC(CCCCCCCCCCCCCC)CC(=O)O | InChi: | InChI=1S/C17H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16(18)15-17(19)20/h16H,2-15,18H2,1H3,(H,19,20)/t16-/m1/s1 | Synonyms: | N-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3S,4S,5R,6R)-4-[(2S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl
)-3-oxo-oxan-2-yl]oxy-3,5-dihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl
]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanamide | Definition date: | 2022-02-16 | Last modified: | 2023-11-03 | Release date: | 2023-03-01 | Identifier: | (3R)-3-aminoheptadecanoic acid |
|